Cancer patients’s survival time & insurance status

Influence of insurance status on survival of adults with glioblastoma multiforme: A population-based study
Xiaoming Rong MD, et al.
Cancer. 8 August 2016

Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumors
Sarah C. Markt ScD, et al.
Cancer. 8 August 2016

The Toxins of William B. Coley

Training The Immune System To Fight Cancer Has 19th-Century Roots
December 28, 2015

A novel immunotherapy drug is credited for successfully treating former President Jimmy Carter’s advanced melanoma. Instead of killing cancer cells, these drugs boost the patient’s immune system, which does the job instead.

Immunotherapy is cutting-edge cancer treatment, but the idea dates back more than 100 years, to a young surgeon who was willing to think outside the box.

The Toxins of William B. Coley and the Treatment of Bone and Soft-Tissue Sarcomas
Edward F McCarthy, MD
Iowa Orthop J. 2006; 26: 154–158.

NFL Player Beats Cancer

NFL Player Beats Cancer, Returns To The Field
September 17, 2015

Kansas City Chiefs safety Eric Berry played his first regular season NFL game last weekend, just 10 months after he was diagnosed with Hodgkin’s lymphoma.

Other professional athletes, such as hockey player Mario Lemieux and baseball player Jon Lester, have also recovered from lymphoma and resumed their careers.

Melanoma: Explosion Of New Cancer Treatments

Explosion Of New Cancer Treatments Presents A ‘Very Exciting Time’
August 20, 2015

with melanoma ’cause about five years ago, I would’ve said he has a prognosis of somewhere between six months to a year. But over the last five years, the treatments in melanoma have just exploded with really, really exciting new treatments that have changed that to a point that we actually don’t have a good estimate yet in terms of long-term prognosis will be.

Trying A Skin Cancer Drug To Treat A Brain Tumor

Why Doctors Are Trying A Skin Cancer Drug To Treat A Brain Tumor
March 26, 2015

Anselmo’s tumor had a BRAF mutation common in skin cancer, but very unusual for a brain tumor.

Her oncologist, David Hyman at Memorial Sloan Kettering, enrolled Anselmo into a new kind of drug trial. Called a basket trial, the study is designed to include people whose tumors have the same kind of genetic fingerprint regardless of where in the body the tumors are found.

Today, Anselmo is doing well. She’s been in the clinical trial for a year now, and continues to take Zelboraf (or vemurafenib generically) daily. The pills have kept her cancer from growing.

There are side effects, of course. She’s lost some peripheral vision, though she’s been able to compensate. And Zelboraf is expensive

After all the misfortunes she’s been through, it would be easy to think Anselmo has been incredibly unlucky. But she doesn’t see it that way. No, she says after rehearsing for her comeback show, “I’m the luckiest.”

Carcinogen In Colas Has FDA Reviewing Data

Potential Carcinogen In Colas Has FDA Reviewing Data
January 23, 2014

A new study from Consumer Reports finds varying levels of a chemical compound classified as a possible human carcinogen in many popular brands of soda.

The findings have prompted the Food and Drug Administration to take a new look at the compound, 4-methylimidazole — or 4-MEI for short. It is found in the caramel color that soda makers use to dye the drinks brown.

Under California’s Prop 65, the chemical is included on a state list of substances that can cause cancer. An arm of the World Health Organization has classified 4-MEI as a possible carcinogen.

Testing by Consumer Reports found very low levels of 4-MEI in Coca-Cola, Coke Zero and Diet Coke.
As we’ve reported, 4-MEI was greatly reduced in Coke products after Coke worked with its supplier to reformulate the caramel manufacturing process.

But the study did find higher levels of the compound in some Pepsi products, particularly in Pepsi One. During an eight-month period, the researchers purchased a dozen 12-ounce servings of Pepsi One from different batches at stores in California.